Esophageal Cancer: This is the core primary disease involved in this study, serving as the baseline diagnosis for all enrolled patients.Anastomotic Leakage: This is the specific complication of interest in this study, and the target variable of the predictive model (clinically, it can also be considered a severe postoperative symptom/sign).
Conditions
Interventions
Observational group:None
Sponsors
Nanjing First Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients who underwent esophagectomy for esophageal cancer between January 2020 and December 2025 were enrolled in this study.
Exclusion criteria
Exclusion criteria: 1.neoadjuvant therapy; 2.prior upper gastrointestinal surgery; 3.missing clinical early postoperative biomarkers; 4.incomplete clinicopathological records;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total Pathological Complete Response Rate (tpCR); | — |
Secondary
| Measure | Time frame |
|---|---|
| Breast Pathological Complete Response Rate (bpCR);Objective Response Rate (ORR);Proportion of Patients with Residual Cancer Burden (RCB) Score 0/I;Change in Ki67 Expression Level; | — |
Countries
China
Contacts
Public ContactZhang Aiping
Nanjing First Hospital
Outcome results
None listed